About Us

Mission

More details are available here.

Corporate History

More details are available here.

What is “onco”

More details are available here.

Business Outline

More details are available here.

Trade name	OncoTherapy Science, Inc. (OTS)
Address	1-2 Higashida-cho, Kawasaki-ku, Kawasaki City, Kanagawa Prefecture 210-0005, Japan Tel: 044-201-6429 Fax: 044-201-6473
Foundation	April 6, 2001
Capital	647 Million JPY (Capital surplus 26.9 billion JPY)
Fiscal year end	March
Board Members	President & CEO　　 Junichi Shimada Chairman　　 Hatsuo Kato Director　　 Jae-Hyun Park Director(External Director)　　 Yoshio Miki Director(External Director)　　 Yuichi Komine Auditor 　　　　　　　　 Yuka Yamane Auditor(External Auditor) 　　 Miyako Takagi Auditor(External Auditor) 　　 Teruhisa Tajima

Associated Companies

Subsidiary

Cancer Precision Medicine, Inc. (CPM)

Business Description	The genome analysis of cancer, liquid biopsy, and development of new immunotherapy including the neoantigen prediction. *
Address	1-2 Higashida-cho, Kawasaki-ku, Kawasaki City, Kanagawa Prefecture 210-0005, Japan
Website	https://www.cancerprecision.co.jp/

*In 2017, OncoTherapy Science, Inc. transferred the function of Tumor Immunology Department (development of cancer immunotherapies, TCR/BCR repertoire analysis) to CPM.

System Requirements

Browsers:Using older browsers, non-compatible browsers or disabling browser features,

such as JavaScript, cookies and SSL, may reduce site functionality.

Supported Browsers

■Windows

・Microsoft Edge later

・Mozilla Firefox later

・GoogleChrome later

■Mac OS

・Safari later

・GoogleChrome later

・Mozilla Firefox later